Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity.
|
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
2pFTFUFUqbb4wKEL